Bellevue Group »

Blackrock shares owned by Bellevue Group

Quarter-by-quarter ownership of Blackrock (BLK) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Blackrock

Tip: Access up to 7 years of quarterly data

All positions including Blackrock held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blackrock by Bellevue Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $482k 450 1070.34

More positions owned by Bellevue Group

Revolution Medicines (RVMD)
Argenx Se Sponsored Adr (ARGX)
Ionis Pharmaceuticals (IONS)
Vertex Pharmaceuticals Incorporated (VRTX)
Neurocrine Biosciences (NBIX)
Avidity Biosciences Ord (RNA)
Intuitive Surgical Com New (ISRG)
Scholar Rock Hldg Corp (SRRK)
Alnylam Pharmaceuticals (ALNY)
Abbott Laboratories (ABT)
Amicus Therapeutics (FOLD)
Boston Scientific Corporation (BSX)
Miragen Therapeutics (VRDN)
Stryker Corporation (SYK)
Nuvalent Inc-a (NUVL)

View all positions for Bellevue Group

Top funds holding Blackrock

Vanguard Group
BlackRock
State Street Corporation
CI Private Wealth
Temasek Holdings
Capital Research Global Investors
Geode Capital Management
Norges Bank Investment Management
Wells Fargo & Company
Rockefeller Capital Management
Franklin Resources
FMR
Capital Research and Management Company - Division 3
Fisher Investments
Ameriprise Financial

View all funds holding Blackrock